Search

Search Constraints

You searched for: Author/Creator Ladenson, Jack H.

Search Results

1. [O1–05–04]: CLINICAL PERFORMANCE OF NEUROGRANIN AS A CEREBROSPINAL FLUID BIOMARKER FOR ALZHEIMER's DISEASE: AN ASSAY COMPARISON STUDY. (1st July 2017)

3. Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease. Issue 5 (4th March 2019)

4. Expression of the Regenerating Gene Family in Inflammatory Bowel Disease Mucosa: Reg Iα Upregulation, Processing, and Antiapoptotic Activity. (1st November 2002)

5. Group VIB Phospholipase A2 Promotes Proliferation of INS-1 Insulinoma Cells and Attenuates Lipid Peroxidation and Apoptosis Induced by Inflammatory Cytokines and Oxidant Agents. (11th November 2012)

7. O3‐14‐01: NOVEL CSF BIOMARKERS OF NEURONAL INJURY, SYNAPTIC DYSFUNCTION AND NEUROINFLAMMATION IN AUTOSOMAL DOMINANT ALZHEIMER DISEASE: VILIP‐1, NEUROGRANIN, SNAP‐25 AND YKL‐40 IN THE DOMINANTLY INHERITED ALZHEIMER NETWORK (DIAN). (1st July 2006)

8. O5‐05‐03: Neurogranin, a CSF biomarker for synaptic loss, predicts decline to dementia due to Alzheimer's disease. (1st July 2015)

9. Obstructive sleep apnea decreases central nervous system–derived proteins in the cerebrospinal fluid. Issue 1 (1st June 2016)

10. P1‐006: Emerging CSF Biomarkers of Neuroinflammation, Neuronal Injury And Synaptic Integrity in the Adni Cohort. (1st July 2016)